Biotechnology Instruments Market Size and Outlook 2030

Report Description

Forecast Period	2026-2030
Market Size (2024)	USD 90.52 Billion
CAGR (2025-2030)	3.55%
Fastest Growing Segment	Analytical Instrument
Largest Market	North America
Market Size (2030)	USD 111.62 Billion

Market Overview

The Global Biotechnology Instruments Market will grow from USD 90.52 Billion in 2024 to USD 111.62 Billion by 2030 at a 3.55% CAGR. Biotechnology instruments encompass the specialized equipment and devices employed for analyzing, manipulating, and understanding biological materials and systems, essential for research and development across medical, agricultural, and environmental sectors. The market's growth is primarily driven by the escalating prevalence of chronic diseases, which necessitates advanced diagnostic and therapeutic solutions, alongside increasing investments in pharmaceutical and biotechnology research and development. Furthermore, the growing focus on precision medicine, demanding sophisticated tools for genetic analysis and drug discovery, significantly propels market expansion.

However, a notable challenge impeding market expansion is the substantial capital investment required for acquiring and maintaining advanced biotechnology instruments, along with the associated consumables. This financial barrier can limit adoption, particularly for smaller research institutions. According to the Advanced Medical Technology Association (AdvaMed), in 2024, the organization represented over 600 companies within the medical technology spectrum, underscoring the extensive industrial foundation contributing to this market.

Key Market Drivers

Two pivotal factors significantly influencing the global biotechnology instruments market are advancements in genomics and proteomics research and the robust growth of the biopharmaceutical industry. Progress in genomics and proteomics continues to expand the understanding of biological systems at a molecular level, necessitating advanced instrumentation for deep analysis. These scientific endeavors drive demand for high-throughput sequencing platforms, sophisticated mass spectrometers, and integrated bioinformatics solutions crucial for unraveling complex biological pathways and identifying biomarkers. For instance, according to the University of Copenhagen, in September 2025, Proteomics Research Infrastructure received 90 million DKK from the Novo Nordisk Foundation to advance its facilities and services, directly fueling the need for state-of-the-art proteomics technology. This continuous push toward deeper insights into genetic and protein functions mandates ongoing innovation and investment in specialized biotechnology instruments.

Concurrently, the expansion of the biopharmaceutical industry is a substantial catalyst for market growth, creating consistent demand for instruments throughout the drug discovery, development, and manufacturing pipeline. Biopharmaceutical companies rely heavily on biotechnology instruments for cell culture, fermentation, purification, and quality control processes in the production of biologics, vaccines, and cell and gene therapies. This industrial growth translates directly into increased procurement of bioreactors, chromatography systems, and analytical tools. Supporting this trend, according to BioSpace, in May 2025, drugmakers worldwide pumped nearly $288 billion into research and development in 2024, highlighting significant investment that underpins instrument demand. This expanding research and production capacity drives instrument sales and service contracts. Overall, the biotechnology instruments market demonstrates sustained expansion, with a leading firm, according to Thermo Fisher Scientific Inc., in October 2025, reporting its third-quarter revenue grew 5% to $11.12 billion.

Download Free Sample Report

Key Market Challenges

The substantial capital investment required for acquiring and maintaining biotechnology instruments and their associated consumables presents a significant challenge to the growth of the global biotechnology instruments market. This financial barrier directly hampers market expansion by limiting the adoption of new technologies, particularly for smaller research institutions, startup companies, and those with constrained budgets. The high initial purchase price for advanced analytical and processing equipment, combined with ongoing costs for specialized reagents, software licenses, and skilled personnel, creates a considerable economic hurdle. Such financial strain can lead to delayed upgrades or deferred investments in essential instrumentation, hindering research capabilities and development timelines across medical, agricultural, and environmental sectors.

These capital demands are exacerbated by rising operational expenditures. According to MedTech Europe's 2024 Regulatory Survey, medical device manufacturers anticipate a 50% increase in maintenance and re-certification costs by the end of a five-year cycle, with IVD manufacturers facing a 70% rise. These escalating operational costs further reduce the capital available for new instrument procurement, thereby slowing the overall market's growth trajectory and limiting access to innovative tools necessary for scientific advancement and product development.

Key Market Trends

The demand for miniaturized and portable biotechnology instruments is significantly increasing due to a focus on decentralized testing and point-of-care diagnostics. This trend enables faster analysis closer to the patient or sample, enhancing accessibility and reducing diagnostic turnaround times across diverse settings, from remote clinics to emergency response scenarios. These advancements move diagnostic capabilities beyond traditional centralized laboratories, fostering more immediate and widespread health management. According to MedTech Europe, in 2024, over 15,700 medical technology patents were filed, showcasing a strong commitment to innovation within the sector, which directly supports the development of compact, field-deployable solutions. For instance, Thermo Fisher Scientific launched the TruScan G3 Handheld Raman Analyzer in March 2024, designed for rapid raw material identification in pharmaceutical and biotechnology applications.

The biotechnology instruments market is undergoing a transformative shift through the integration of advanced technologies such as Artificial Intelligence, Internet of Things, and Robotics. These technologies are crucial for improving operational efficiency, automating complex laboratory workflows, and enhancing the precision of data analysis. IoT facilitates real-time monitoring and data collection from instruments, while AI-enabled systems streamline processes and reduce human error, accelerating discovery and development cycles. Regulatory bodies are actively adapting to this rapid innovation; according to RAPS, in April 2025, FDA officials stated the agency had authorized over 1,000 AI-enabled devices through established premarket pathways, indicating a growing acceptance and integration of AI in medical technology. Further demonstrating this trend, Danaher announced a partnership with AstraZeneca in May 2025 to develop AI-powered diagnostics aimed at scaling precision medicine.

Segmental Insights

Within the dynamic Global Biotechnology Instruments Market, the Analytical Instrument segment stands out as the fastest-growing product category. This rapid expansion is primarily driven by escalating research and development activities across the life sciences sector, particularly within pharmaceutical and biotechnology companies. These industries increasingly demand highly precise and efficient analytical solutions for critical applications such as drug discovery, development, and stringent quality control. Furthermore, continuous technological advancements, including enhanced automation and data analysis capabilities, significantly contribute to the segment's growth. The imperative for adhering to rigorous regulatory guidelines set by bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) also fuels the demand for reliable analytical instruments, ensuring product safety and efficacy.

Regional Insights

North America holds a leading position in the global biotechnology instruments market, primarily attributed to its extensive research and development ecosystem and significant public and private investments in the biotechnology sector. This robust environment fosters innovation and the swift adoption of advanced technologies. The region also benefits from a highly developed healthcare infrastructure and the strong presence of major pharmaceutical and biotechnology companies, alongside prominent academic and research institutions. Moreover, increasing demand for personalized medicine and the prevalent burden of chronic diseases drive the need for sophisticated diagnostic and therapeutic instruments. A supportive regulatory framework, including the oversight of related products by bodies such as the U.S. Food and Drug Administration, further contributes to market growth.

Recent Developments

In October 2024, Univercells Technologies, a company operating under Donaldson Life Science, launched the scale-X™ nexo Mini Bioreactor. This new product represents an advancement in biotechnology instruments for bioprocessing applications. The introduction of this bioreactor expands Donaldson's product portfolio, which is aimed at providing comprehensive and differentiated solutions to customers in the life sciences market. The new bioreactor is designed to support various levels of scalable biomanufacturing cell culture, addressing critical needs in biopharmaceutical production.

In June 2024, GenScript Biotech Corporation introduced its new FLASH Gene service, an ultra-fast sequence-to-plasmid (S2P) solution. This offering provides gene constructs with rapid delivery times, high quality, and cost-efficiency. The service guarantees plasmid yield and 100% sequence accuracy, offering a flat-rate pricing model starting at $89 for gene synthesis, cloning, and plasmid preparation. This advancement aims to significantly accelerate research and discovery efforts in the development of various biopharmaceutical products, impacting the services that utilize biotechnology instruments.

In June 2024, NanoImaging Services and Cube Biotech announced a strategic partnership to develop a streamlined, cryo-electron microscopy (cryo-EM) enabled gene-to-structure workflow. This collaboration aims to accelerate medicinal chemistry analysis and advance membrane protein research. The partnership leverages NanoImaging Services' expertise in high-resolution structural enablement by cryo-EM and Cube Biotech's proprietary polymer technologies and protein production platform. This initiative focuses on managing projects from construct design to final structural maps, enhancing capabilities within the biotechnology instruments sector.

In May 2024, Ori Biotech Ltd., a company specializing in cell and gene therapy manufacturing technology, commercially launched its IRO® platform. This next-generation platform was developed to address existing challenges in cell and gene therapy manufacturing, aiming to enhance patient access to these therapies. The IRO platform provides flexibility for early process development and can scale into GMP manufacturing using the same instrumentation and consumables. This innovation streamlines the transition from research and development to good manufacturing practice, contributing to the efficiency of the biotechnology instruments market.

Key Market Players

Thermo Fisher Scientific, Inc.
Shimadzu Corp.
Agilent Technologies, Inc.
Bruker Corp.
PerkinElmer, Inc.
Zeiss Group
Bio-Rad Laboratories, Inc.
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Sartorius AG

By Product	By End-use	By Region
Cell Culture Instruments Analytical Instruments Cell Separation Instruments Immunoassay Instruments Clinical Chemistry Analyzers Others	Hospitals & Diagnostic Laboratories Pharmaceutical & Biotechnology Companies Academic & Research Institutes Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Biotechnology Instruments Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biotechnology Instruments Market, By Product:

o Cell Culture Instruments

o Analytical Instruments

o Cell Separation Instruments

o Immunoassay Instruments

o Clinical Chemistry Analyzers

o Others

Biotechnology Instruments Market, By End-use:

o Hospitals & Diagnostic Laboratories

o Pharmaceutical & Biotechnology Companies

o Academic & Research Institutes

o Others

Biotechnology Instruments Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ France

§ United Kingdom

§ Italy

§ Germany

§ Spain

o Asia Pacific

§ China

§ India

§ Japan

§ Australia

§ South Korea

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biotechnology Instruments Market.

Available Customizations:

Global Biotechnology Instruments Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Biotechnology Instruments Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biotechnology Instruments Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product (Cell Culture Instruments, Analytical Instruments, Cell Separation Instruments, Immunoassay Instruments, Clinical Chemistry Analyzers, Others)

5.2.2. By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)

5.2.3. By Region

5.2.4. By Company (2024)

5.3. Market Map

6. North America Biotechnology Instruments Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product

6.2.2. By End-use

6.2.3. By Country

6.3. North America: Country Analysis

6.3.1. United States Biotechnology Instruments Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product

6.3.1.2.2. By End-use

6.3.2. Canada Biotechnology Instruments Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product

6.3.2.2.2. By End-use

6.3.3. Mexico Biotechnology Instruments Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product

6.3.3.2.2. By End-use

7. Europe Biotechnology Instruments Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product

7.2.2. By End-use

7.2.3. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Biotechnology Instruments Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product

7.3.1.2.2. By End-use

7.3.2. France Biotechnology Instruments Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product

7.3.2.2.2. By End-use

7.3.3. United Kingdom Biotechnology Instruments Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product

7.3.3.2.2. By End-use

7.3.4. Italy Biotechnology Instruments Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product

7.3.4.2.2. By End-use

7.3.5. Spain Biotechnology Instruments Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product

7.3.5.2.2. By End-use

8. Asia Pacific Biotechnology Instruments Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product

8.2.2. By End-use

8.2.3. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Biotechnology Instruments Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product

8.3.1.2.2. By End-use

8.3.2. India Biotechnology Instruments Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product

8.3.2.2.2. By End-use

8.3.3. Japan Biotechnology Instruments Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product

8.3.3.2.2. By End-use

8.3.4. South Korea Biotechnology Instruments Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product

8.3.4.2.2. By End-use

8.3.5. Australia Biotechnology Instruments Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product

8.3.5.2.2. By End-use

9. Middle East & Africa Biotechnology Instruments Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product

9.2.2. By End-use

9.2.3. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Biotechnology Instruments Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product

9.3.1.2.2. By End-use

9.3.2. UAE Biotechnology Instruments Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product

9.3.2.2.2. By End-use

9.3.3. South Africa Biotechnology Instruments Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product

9.3.3.2.2. By End-use

10. South America Biotechnology Instruments Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product

10.2.2. By End-use

10.2.3. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Biotechnology Instruments Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product

10.3.1.2.2. By End-use

10.3.2. Colombia Biotechnology Instruments Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product

10.3.2.2.2. By End-use

10.3.3. Argentina Biotechnology Instruments Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product

10.3.3.2.2. By End-use

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Biotechnology Instruments Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Thermo Fisher Scientific, Inc.

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Shimadzu Corp.

15.3. Agilent Technologies, Inc.

15.4. Bruker Corp.

15.5. PerkinElmer, Inc.

15.6. Zeiss Group

15.7. Bio-Rad Laboratories, Inc.

15.8. Illumina, Inc.

15.9. F. Hoffmann-La Roche Ltd

15.10. Sartorius AG

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Biotechnology Instruments Market in 2024?

Which is the dominating region in the Global Biotechnology Instruments Market?

Which is the fastest growing segment in the Global Biotechnology Instruments Market?

What is the expected growth rate of the Global Biotechnology Instruments Market?